T422-0818 Screening compound: N-{[4-(morpholin-4-yl)phenyl]methyl}-3-{1-[6-(propylamino)pyrimidin-4-yl]piperidin-4-yl}propanamide

T422-0818 Screening compound: N-{[4-(morpholin-4-yl)phenyl]methyl}-3-{1-[6-(propylamino)pyrimidin-4-yl]piperidin-4-yl}propanamide
T422-0818 Screening compound: N-{[4-(morpholin-4-yl)phenyl]methyl}-3-{1-[6-(propylamino)pyrimidin-4-yl]piperidin-4-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T422-0818
N-{[4-(morpholin-4-yl)phenyl]methyl}-3-{1-[6-(propylamino)pyrimidin-4-yl]piperidin-4-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T422-0818

Molecular Formula

C26H38N6O2 (C26 H38 N6 O2)

Compound Name

N-{[4-(morpholin-4-yl)phenyl]methyl}-3-{1-[6-(propylamino)pyrimidin-4-yl]piperidin-4-yl}propanamide

IUPAC name

N-{[4-(morpholin-4-yl)phenyl]methyl}-3-{1-[6-(propylamino)pyrimidin-4-yl]piperidin-4-yl}propanamide

SMILES

CCCNc1cc(N2CCC(CCC(NCc(cc3)ccc3N3CCOCC3)=O)CC2)ncn1

InChI

InChI=1S/C26H38N6O2/c1-2-11-27-24-18-25(30-20-29-24)32-12-9-21(10-13-32)5-8-26(33)28-19-22-3-6-23(7-4-22)31-14-16-34-17-15-31/h3-4,6-7,18,20-21H,2,5,8-17,19H2,1H3,(H,28,33)(H,27,29,30)

InChI Key

IVFMVRWXDNNBST-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27620857

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.63

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.106

Distribution Coefficient, logD

4.099

Water Solubility, LogSw

-4.05

Polar Surface Area

69.440

Acid Dissociation Constant (pKa)

13.88

Base Dissociation Constant (pKb)

5.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

57.70

T422-0818 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Eccentric PPI Library (11937 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with T422-0818 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T422-0818?
Check Price and Availability of T422-0818, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T422-0818 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T422-0818
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T422-0818
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T422-0818 available by request